FCN

FTI Consulting, Inc.

61
Fundamentals59/ 100
Valuation47/ 100
Upside potential43/ 100
Risk potential19/ 100

FCN has the edge over RKLB overall, supported by lower modeled downside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

FCN Fundamentals

MetricStatus
Stable
Healthy
Healthy
Stable

FCN's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

FCN PE Valuation

CHEAPFAIREXPENSIVE8.5x17x26x34x
CHEAPFAIREXPENSIVE8.5x17x26x34x
LevelPEPriceVs current
Forward19x$199—
Cheap21x$165-17%
Fair23x$183-8.1%
Current25x$199—
Expensive27x$217+9.4%

Historical ranges are pointers, not guarantees.

FCN's PE is in its expensive range at 25x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

FCN Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
High

Analysts expect earnings and revenue growth for FCN, with profitability improving.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

FCN Risk to reward

ScenarioChangePrice
Upside+14%$226.30
Downside-19%$161.44

Calculated from the latest close: $198.62 on Nov 12.

FCN trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than FCN, with more potential upside relative to its potential downside.

FCN Earnings Per Share

Q4 2023: $7.71Q1 2024: $8.60Q2 2024: $9.19Q3 2024: $8.70Q4 2024: $7.81Q1 2025: $7.32Q2 2025: $7.11Q3 2025: $7.86Q4 2025: $8.24Q1 2026: $8.40Q2 2026: $8.26Q3 2026: $8.01Forward: $10.47
Q4 2023: $7.71Q1 2024: $8.60Q2 2024: $9.19Q3 2024: $8.70Q4 2024: $7.81Q1 2025: $7.32Q2 2025: $7.11Q3 2025: $7.86Q4 2025: $8.24Q1 2026: $8.40Q2 2026: $8.26Q3 2026: $8.01Forward: $10.47
QuarterTTM EPSYoY
Forward$10.47+31%
Q3 2026$8.01+1.9%
Q2 2026$8.26+16%
Q1 2026$8.40+15%
Q4 2025$8.24+5.5%
Q3 2025$7.86-9.7%
Q2 2025$7.11-23%
Q1 2025$7.32-15%
Q4 2024$7.81+1.3%

FCN has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

FCN Quarterly Revenue

Q4 2023: $925MQ1 2024: $929MQ2 2024: $949MQ3 2024: $926MQ4 2024: $895MQ1 2025: $898MQ2 2025: $944MQ3 2025: $956MQ4 2025: $991MQ1 2026: $983MQ2 2026: $993MQ3 2026: $1B
Q4 2023: $925MQ1 2024: $929MQ2 2024: $949MQ3 2024: $926MQ4 2024: $895MQ1 2025: $898MQ2 2025: $944MQ3 2025: $956MQ4 2025: $991MQ1 2026: $983MQ2 2026: $993MQ3 2026: $1B
QuarterRevenueYoY
Q3 2026$1B+5.9%
Q2 2026$993.5M+5.3%
Q1 2026$983.3M+9.5%
Q4 2025$990.7M+11%
Q3 2025$956.2M+3.3%
Q2 2025$943.7M-0.6%
Q1 2025$898.3M-3.3%
Q4 2024$894.9M-3.2%

FCN's revenue has grown year over year for five quarters in a row: $1B last quarter, up 5.9% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over FCN on sales, with more consistent year-over-year improvement.

FCN Free Cash Flow

Q4 2023: $377MQ1 2024: −$279MQ2 2024: $125MQ3 2024: $212MQ4 2024: $302MQ1 2025: −$483MQ2 2025: $38MQ3 2025: $187MQ4 2025: $351MQ1 2026: −$321MQ2 2026: $141MQ3 2026: $182M
Q4 2023: $377MQ1 2024: −$279MQ2 2024: $125MQ3 2024: $212MQ4 2024: $302MQ1 2025: −$483MQ2 2025: $38MQ3 2025: $187MQ4 2025: $351MQ1 2026: −$321MQ2 2026: $141MQ3 2026: $182M
QuarterFree cash flowYoY
Q3 2026$182M-2.7%
Q2 2026$141M+269%
Q1 2026-$320.6M+$162.4M
Q4 2025$351.4M+16%
Q3 2025$187M-12%
Q2 2025$38.3M-69%
Q1 2025-$483M-$203.6M
Q4 2024$301.6M-20%

FCN has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

FCN Total Shares

Q4 2023: 36MQ1 2024: 36MQ2 2024: 36MQ3 2024: 36MQ4 2024: 36MQ1 2025: 36MQ2 2025: 34MQ3 2025: 32MQ4 2025: 33MQ1 2026: 30MQ2 2026: 29MQ3 2026: 27M
Q4 2023: 36MQ1 2024: 36MQ2 2024: 36MQ3 2024: 36MQ4 2024: 36MQ1 2025: 36MQ2 2025: 34MQ3 2025: 32MQ4 2025: 33MQ1 2026: 30MQ2 2026: 29MQ3 2026: 27M
PeriodChange %Net change
Quarterly-7.1%-2M shares
1 year-15%-4.8M shares
3 years-24%-8.7M shares
5 years-24%-8.4M shares
Available history-29%-11.1M shares

FCN has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

FCN Net Leverage

Q4 2023: -0.7xQ1 2024: -0.1xQ2 2024: -0.4xQ3 2024: -0.9xQ4 2024: -1.7xQ1 2025: 0.0xQ2 2025: 0.9xQ3 2025: 0.9xQ4 2025: 0.2xQ1 2026: 1.3xQ2 2026: 2.0xQ3 2026: 1.9x
Q4 2023: -0.7xQ1 2024: -0.1xQ2 2024: -0.4xQ3 2024: -0.9xQ4 2024: -1.7xQ1 2025: 0.0xQ2 2025: 0.9xQ3 2025: 0.9xQ4 2025: 0.2xQ1 2026: 1.3xQ2 2026: 2.0xQ3 2026: 1.9x
QuarterNet LeverageStatus
Q3 20261.9xHealthy
Q2 20262.0xHealthy
Q1 20261.3xHealthy
Q4 20250.2xVery low
Q3 20250.9xVery low
Q2 20250.9xVery low
Q1 20250.0xVery low
Q4 2024-1.7xNet Cash

FCN's net debt is about 1.9 years of its operating earnings (EBITDA), up from less than a year a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

FCN Weekly Momentum

MetricValueStatus
RSI71.1Overbought
Stochastic93.8Overbought

FCN's weekly RSI is 71 (overbought) and its Stochastic is 94 (overbought).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

FCN PE vs Industrials Sector

MetricFCNSector medianRelative
PE25x24x3% above
PE %685810 pts above

FCN is trading at 25x earnings, in line with the Industrials sector's median of 24x.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

FCN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$161.223% above
20 week MA$156.827% above
50 week MA$163.621% above
100 week MA$166.319% above
200 week MA$183.68.2% above

FCN has the edge over RKLB on trend strength, trading above more of its moving averages.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

FCN Yearly ROI

YearStart priceEnd priceROI
2020$110.6$111.1+0.4%
2021$111.1$150.8+36%
2022$150.8$156.9+4%
2023$156.9$199.2+27%
2024$199.2$192.9-3.1%
2025$192.9$175.5-9%
2026 YTD$175.5$198.6+13%

FCN has the edge over RKLB on returns for 2026, with the stronger performance.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.

Give your agent the market.

Get API key